Literature DB >> 12405158

Cytotoxic HIV-1 p55gag-specific CD4+ T cells produce HIV-inhibitory cytokines and chemokines.

Barbara Lotti1, Thomas Wendland, Hansjakob Furrer, Nikhil Yawalkar, Salome von Greyerz, Karin Schnyder, Marlène Brandes, Pietro Vernazza, Ralf Wagner, Thi Nguyen, Eric Rosenberg, Werner J Pichler, Christian Brander.   

Abstract

CD4+ T-helper cells appear to be essential in sustaining immune responses in chronic viral infections, as the maintenance of CD8+ cytotoxic T-lymphocyte responses and the control of viremia were demonstrated to depend on CD4+ T cell help. In order to investigate the function of HIV-specific CD4+ T cells in chronic HIV-1-infection, 49 chronically HIV-infected patients were analyzed before and 3 and 6 months after initiation of antiviral treatment. Ten patients showed a substantial, although weak, proliferative response to HIV-1-p55gag protein for which no improvement was observed upon initiation of HAART. From one individual, HIV-1-p55gag-specific CD4-positive T-cell clones were generated that were heterogeneous in their TCR Vbeta gene usage and HLA-DRB1*13 and DRB1*03 restricted, respectively. In addition, some CD4+ TCC produced substantial amounts of IFN-gamma and MIP-1alpha/beta were perforin-positive, and showed cytotoxic activity. These diverse functional features of HIV-specific CD4+ T cells suggest that they may exert direct antiviral activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12405158     DOI: 10.1023/a:1020066404226

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  46 in total

1.  Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.

Authors:  B Autran; G Carcelain; T S Li; C Blanc; D Mathez; R Tubiana; C Katlama; P Debré; J Leibowitch
Journal:  Science       Date:  1997-07-04       Impact factor: 47.728

Review 2.  HIV-induced immunopathogenesis.

Authors:  G M Shearer
Journal:  Immunity       Date:  1998-11       Impact factor: 31.745

3.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.

Authors:  T Dragic; V Litwin; G P Allaway; S R Martin; Y Huang; K A Nagashima; C Cayanan; P J Maddon; R A Koup; J P Moore; W A Paxton
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

4.  Induction of CD4+ human cytolytic T cells specific for HIV-infected cells by a gp160 subunit vaccine.

Authors:  R J Orentas; J E Hildreth; E Obah; M Polydefkis; G E Smith; M L Clements; R F Siliciano
Journal:  Science       Date:  1990-06-08       Impact factor: 47.728

5.  Expression of two T cell receptor alpha chains: dual receptor T cells.

Authors:  E Padovan; G Casorati; P Dellabona; S Meyer; M Brockhaus; A Lanzavecchia
Journal:  Science       Date:  1993-10-15       Impact factor: 47.728

Review 6.  The immunomodulatory role of CD4-positive cytotoxic T-lymphocytes in health and disease.

Authors:  S Hahn; P Erb
Journal:  Int Rev Immunol       Date:  1999       Impact factor: 5.311

7.  A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

Authors:  S M Hammer; K E Squires; M D Hughes; J M Grimes; L M Demeter; J S Currier; J J Eron; J E Feinberg; H H Balfour; L R Deyton; J A Chodakewitz; M A Fischl
Journal:  N Engl J Med       Date:  1997-09-11       Impact factor: 91.245

8.  CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.

Authors:  M Matloubian; R J Concepcion; R Ahmed
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group.

Authors:  A C Collier; R W Coombs; D A Schoenfeld; R L Bassett; J Timpone; A Baruch; M Jones; K Facey; C Whitacre; V J McAuliffe; H M Friedman; T C Merigan; R C Reichman; C Hooper; L Corey
Journal:  N Engl J Med       Date:  1996-04-18       Impact factor: 91.245

10.  Viral immune evasion due to persistence of activated T cells without effector function.

Authors:  A J Zajac; J N Blattman; K Murali-Krishna; D J Sourdive; M Suresh; J D Altman; R Ahmed
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

View more
  6 in total

1.  Major histocompatibility complex class II (HLA-DRB and -DQB) allele frequencies in Botswana: association with human immunodeficiency virus type 1 infection.

Authors:  Thumbi Ndung'u; Simani Gaseitsiwe; Enoch Sepako; Florence Doualla-Bell; Trevor Peter; Soyeon Kim; Ibou Thior; Vladimir A Novitsky; Max Essex
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

2.  Antigen stimulation induces HIV envelope gp120-specific CD4(+) T cells to secrete CCR5 ligands and suppress HIV infection.

Authors:  Gurvinder Kaur; Michael Tuen; Diana Virland; Sandra Cohen; Narinder K Mehra; Christian Münz; Sayed Abdelwahab; Alfredo Garzino-Demo; Catarina E Hioe
Journal:  Virology       Date:  2007-09-04       Impact factor: 3.616

3.  Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides.

Authors:  Daniel E Kaufmann; Paul M Bailey; John Sidney; Bradford Wagner; Philip J Norris; Mary N Johnston; Lisa A Cosimi; Marylyn M Addo; Mathias Lichterfeld; Marcus Altfeld; Nicole Frahm; Christian Brander; Alessandro Sette; Bruce D Walker; Eric S Rosenberg
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

4.  Strong ability of Nef-specific CD4+ cytotoxic T cells to suppress human immunodeficiency virus type 1 (HIV-1) replication in HIV-1-infected CD4+ T cells and macrophages.

Authors:  Nan Zheng; Mamoru Fujiwara; Takamasa Ueno; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

Review 5.  Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse model.

Authors:  Savita Nair; Wibke Bayer; Mickaël J Y Ploquin; George Kassiotis; Kim J Hasenkrug; Ulf Dittmer
Journal:  Retrovirology       Date:  2011-09-26       Impact factor: 4.602

6.  Low-replicating viruses and strong anti-viral immune response associated with prolonged disease control in a superinfected HIV-1 LTNP elite controller.

Authors:  María Pernas; Concepción Casado; Carolina Arcones; Anuska Llano; Víctor Sánchez-Merino; Beatriz Mothe; José L Vicario; Eulalia Grau; Lidia Ruiz; Jorge Sánchez; Amalio Telenti; Eloísa Yuste; Christian Brander; Cecilio López- Galíndez
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.